Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred S Lewin

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Plos One|February 22, 2017
Oxidative stress-mediated NFκB phosphorylation upregulates p62/SQSTM1 and promotes retinal pigmented epithelial cell survival through increased autophagyChunjuan Song, Sayak K Mitter, Xiaoping Qi, et al.
Investigative Ophthalmology & Visual Science|October 25, 2014
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profileRajeshwari Koilkonda, Hong Yu, Venu Talla, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vectorArtur V Cideciyan, Raghavi Sudharsan, Valérie L Dufour, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of diseaseWilliam A Beltran, Artur V Cideciyan, Simone Iwabe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 4, 2010
Novel properties of tyrosine-mutant AAV2 vectors in the mouse retinaHilda Petrs-Silva, Astra Dinculescu, Qiuhong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosaWilliam A Beltran, Artur V Cideciyan, Alfred S Lewin, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Plos One|February 22, 2017
Oxidative stress-mediated NFκB phosphorylation upregulates p62/SQSTM1 and promotes retinal pigmented epithelial cell survival through increased autophagyChunjuan Song, Sayak K Mitter, Xiaoping Qi, et al.
Investigative Ophthalmology & Visual Science|October 25, 2014
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profileRajeshwari Koilkonda, Hong Yu, Venu Talla, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2018
Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vectorArtur V Cideciyan, Raghavi Sudharsan, Valérie L Dufour, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of diseaseWilliam A Beltran, Artur V Cideciyan, Simone Iwabe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 4, 2010
Novel properties of tyrosine-mutant AAV2 vectors in the mouse retinaHilda Petrs-Silva, Astra Dinculescu, Qiuhong Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosaWilliam A Beltran, Artur V Cideciyan, Alfred S Lewin, et al.
Pageof 13